United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - cyred® (desogestrel and ethinyl estradiol tablets usp, 0.15 mg/0.03 mg) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1:  percentage of women experiencing an unintended pregnancy during the first year of typic

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - emoquette®  (desogestrel and ethinyl estradiol tablets usp) tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with emoquette® , 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. % of women experiencing an unintended pregnancy within the first year of use typical use1 (2)  perfect use2 (3) emerg

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - emoquette ®  (desogestrel and ethinyl estradiol tablets usp) tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with emoquette ® , 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. % of women experiencing an unintended pregnancy within the first year of use typical use 1 (2)  perfect use 2 (3)

United States - English - NLM (National Library of Medicine)

mineralhouse corporation - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - glycerin 3.25 g in 50 ml - apply on the face or the body thoroughly purpose: skin protectant stop use if allergic reaction or irritation occurs

Ireland - English - HPRA (Health Products Regulatory Authority)

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 4mg/5mg milligram - perindopril and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 4mg/10mg milligram - perindopril and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablet - 8mg/5mg milligram(s) - ace inhibitors and calcium channel blockers; perindopril and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 8mg/10mg milligram - perindopril and amlodipine

United States - English - NLM (National Library of Medicine)

a-s medication solutions - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - wera ™ tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant® system depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. wera ™ has not been studied for and is not indicated for use in emergency contraception. oral contraceptives should not be used in women who currently have the following conditions:

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - ethinyl estradiol 0.03 mg - blisovi fe 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. adapted from ra hatcher et al, reference 7. oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease - known or suspected carcinoma of the breast - carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia - undiagnosed abnormal genital bleeding - cholestatic jaundice of